Oracle Delivers New Oracle Exadata Database Machine

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Oracle Delivers New Oracle Exadata Database Machine

REDWOOD SHORES, CA--(Marketwired - Nov 4, 2015) - Oracle ( NYSE : ORCL )

Available today, the new Oracle Exadata Database Machine X5-8 is the latest in the X5 family of engineered systems. Oracle Exadata integrates hardware and software to deliver the highest performance database deployments at the lowest cost. Each Oracle Exadata X5-8 system offers up to 576 CPU cores, more than 1.3 petabytes of disk storage or 180 terabytes of ultra fast PCIe flash, and up to 24 terabytes of memory .

Oracle Exadata X5-8 is ideal for in-memory databases, large data warehouses, or demanding OLTP workloads. The high compute, storage and memory capacity of the Oracle Exadata X5-8 is designed for large-scale private cloud database initiatives, enabling large numbers of databases with varied workloads to be consolidated onto a single Exadata system, resulting in greatly reduced operational and management costs.

"Oracle Exadata X5-8 is an ideal platform for database cloud deployments as well as in-memory analytics, OLTP and mixed workloads," said Juan Loaiza, senior vice president, Systems Technology, Oracle. "For the last several years, Oracle Exadata has been the platform of choice for running mission critical Oracle databases at thousands of customers, and X5-8 extends this value proposition."

Key features of this hardware release include:

New Database Server: X5-8 updates the 8-socket database servers to use the latest and fastest eighteen-core Intel E7-8895 v3 processors, for a total of 144 cores per database server. The extra cores and updated architecture increase performance up to 25 percent. 

Double Storage Server Capacity: High Capacity Storage Servers included in X5-8 Oracle Exadata Database Machines use 8TB SAS3 disk drives, doubling storage capacity over the prior X4-8 generation. 

Oracle Exadata systems feature unique software capabilities that dramatically accelerate database performance and reduce cost. Oracle Exadata X5-8 ships with the latest Oracle Exadata software release (12.1.2.2.0) that provides the following new capabilities:

  • IPv6 support for Ethernet networks
  • Simpler management and better security using ExaCLI
  • Improved Exadata storage statistics in AWR reports
  • Reverse offload improvements
  • Robustness and availability improvements

Oracle Exadata X5-8 is the new companion model to Oracle Exadata X5-2 and incorporates the same storage and networking capabilities of Oracle Exadata X5-2. Storage and compute can be elastically configured and expanded one server at a time to provide granular on-demand expansion at a lower cost. Elastic configurations enable customized Oracle Exadata Database Machines, such as Oracle Database In-Memory optimized systems or all-flash OLTP systems. Capacity-on-Demand pricing of the database software and the availability of Oracle VM virtualization enable additional flexibility, security and savings. Additionally, the new Oracle Exadata software supports previous-generation Oracle Exadata hardware systems and also supports both Oracle Database 12 c and Oracle Database 11 g Release 2 databases.

Oracle Exadata systems provide customers with a cost-effective database consolidation platform delivered within their enterprise or in the Oracle Cloud . The combination of both on-premises and public cloud capabilities provides enterprises with the maximum flexibility in where to develop and run production database workloads all managed through a single pane of glass with Oracle Enterprise Manager . 

Supporting Resources

About Oracle Oracle offers a comprehensive and fully integrated stack of cloud applications and platform services. For more information about Oracle ( NYSE : ORCL ), visit www.oracle.com .

Trademarks Oracle and Java are registered trademarks of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Info Teri Whitaker Oracle +1.650.506.9914 Email Contact Michelle Jenkins Oracle +1.425.945.8306 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 154

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 136

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 27

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 129

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 150

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading

Top 5 Most Recently Viewed Articles

Coca-Cola's Emerging Markets Strategy Fuels Long-Term Growth

Updated Category News Views 929

Coca-Cola's Position in Emerging Markets Coca-Cola Co (NYSE: KO) stands as a beacon of growth, with a visionary strategy that highlights both immediate and long-term opportunities. The company has successfully positioned itself in vital markets, particularly in North America and Latin America, which have proven central to its success. According to recent insights from...

Continue Reading
Voda IQ Appoints Armando Piccinini to Drive European Sales

Updated Category News Views 121

Voda IQ dropped some big news back in 2024 when they appointed Armando Piccinini as their European Sales Director. This guy’s got over twenty years under his belt in aquatic conservation, which they clearly hope will ramp up their sales strategy across Europe. But you gotta wonder—are the numbers behind this move really there? Can Experience Translate to Sales Growth?...

Continue Reading
Magnera Corporation to Shine at Upcoming Finance Conference

Updated Category News Views 163

Magnera Corporation's Conference Participation Announcement Magnera Corporation (NYSE: MAGN) has made an exciting announcement regarding its upcoming participation in a significant financial event. The company is set to be a part of the 2025 Bank of America Leveraged Finance Conference, aimed at fostering connections with top institutional investors. The event will take...

Continue Reading
Bullish Momentum Unveiled: Insights on Merck & Co Stocks

Updated Category News Views 180

Exciting Developments in Merck & Co Options Activity Notable investors are expressing strong optimism about Merck & Co. A recent analysis of options trading strategies reveals a wave of activity among traders aiming to capitalize on this potential. Options Trading Overview When reviewing the options history for Merck & Co (NYSE: MRK), we found a total of 33 trades that...

Continue Reading
Gilead Snags Arcellx: A High-Stakes Cancer Gamble Unfolds

Updated Category News Views 195

The Big Play for Cancer Innovation Gilead Sciences Inc. (NASDAQ:GILD) pulled the trigger on a pretty huge acquisition deal, landing Arcellx Inc. (NASDAQ:ACLX) this past Monday for a staggering $115 per share, which gets better with a potential extra $5 per share on a contingent value right. That rings in a hefty total of $7.8 billion—no pocket change, folks. What’s...

Continue Reading